Laman Utama2359 • HKG
add
WuXi AppTec Ord Shs H
Tutup sebelumnya
$104.60
Julat hari
$103.20 - $109.20
Julat tahun
$44.30 - $124.70
Permodalan pasaran
325.58B HKD
Bilangan Purata
6.87J
Nisbah P/E
20.86
Hasil dividen
1.36%
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 11.14B | 32.01% |
Perbelanjaan pengendalian | — | — |
Pendapatan bersih | — | — |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | 1.02 | 22.89% |
EBITDA | — | — |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 25.16B | 71.50% |
Jumlah aset | 83.82B | 12.67% |
Jumlah liabiliti | 23.41B | 21.30% |
Jumlah ekuiti | 60.41B | — |
Syer tertunggak | 3.43B | — |
Harga kepada buku | 5.99 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | — | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | — | — |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
The company is listed in mainland China and Hong Kong. Its H‑shares are constituents of the Hang Seng Index, and its A‑shares are included in the FTSE China A50 Index.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. Wikipedia
Diasaskan
1 Dis 2000
Tapak web
Pekerja
37,832
